국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
KCI
KISS
1 Haruhiko Ogata ; Takashi Hagiwara ; Takeshi Kawaberi ; Mariko Kobayashi ; Toshifumi Hibi, "Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study" 대한장연구학회 19 (19): 419-429, 2021
2 Soo-Kyung Park ; Chang Hwan Choi ; 천재영 ; Heeyoung Lee ; Eun Sun Kim ; Jae Jun Park ; Chan Hyuk Park ; Bo-In Lee ; 정윤호 ; 박동일 ; Do Young Kim ; Hana Park ; 진윤태 ; the IBD Research Group of the Korean Association for the Study of Intestinal Diseases, "Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases" 대한장연구학회 18 (18): 18-33, 2020
3 Viget N, "Opportunistic infections in patients with inflammatory bowel disease : prevention and diagnosis" 57 : 549-558, 2008
4 Sahil Khanna, "Management of Clostridioides difficile infection in patients with inflammatory bowel disease" 대한장연구학회 19 (19): 265-274, 2021
5 Ben Musa R, "Hepatitis B vaccination in patients with inflammatory bowel disease" 20 : 15358-15366, 2014
6 Kucharzik T, "ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease" 15 : 879-913, 2021
7 Yang Hong ; Ran Zhihua ; Jin Meng ; Qian Jia-Ming, "Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study" 거트앤리버 소화기연관학회협의회 16 (16): 726-735, 2022
8 Johnson S, "Clinical practice guideline by the Infectious Diseases Society of America(IDSA)and Society for Healthcare Epidemiology of America(SHEA) : 2021 focused update guidelines on management of Clostridioides difficile infection in adults" 73 : 755-757, 2021
9 Bonovas S, "Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease : a systematic review and network meta-analysis" 14 : 1385-1397, 2016
